Cg Oncology Inc.. (CGON) NASDAQ
$28.01 0.69 (2.53%)
Market Cap: $1.82B
As of 05/15/24 04:00 PM EDT. Market closed.
Cg Oncology Inc.. (CGON)
NASDAQ
$28.01
0.69 (2.53%)
Market Cap: $1.82B
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR CG ONCOLOGY INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$27.47
Previous Close
$27.32
Days Range
$26.55 - $28.70
52 week range
$25.77 - $50.23
Volume
910,276
Avg. Volume (30 days)
689,552
Market Cap
$1.82B
Dividend Yield
-
P/E
-
Shares Outstanding
66,640,150
Open
$27.47
Previous Close
$27.32
Days Range
$26.55 - $28.70
52 week range
$25.77 - $50.23
Volume
910,276
Avg. Volume (30 days)
689,552
Market Cap
$1.82B
Dividend Yield
-
P/E
-
Shares Outstanding
66,640,150
FINANCIAL STATEMENTS FOR CG ONCOLOGY INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CG ONCOLOGY INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Jan 29, 2024 | Buy | $19.00 | 400,000 | 7,600,000 | 4,958,810 | Apr 09, 2024, 07:08 PM |
| Kasturi Vijay | Chief Medical Officer | Jan 29, 2024 | Buy | $19.00 | 1,315 | 24,985 | 1,315 | Jan 31, 2024, 04:30 PM |
| Roche Corleen M. | CFO & Secretary | Jan 29, 2024 | Buy | $19.00 | 2,000 | 38,000 | 2,000 | Jan 31, 2024, 04:30 PM |
| Song Hong Fang | Director | Jan 29, 2024 | Buy | $19.00 | 263,157 | 4,999,983 | 613,928 | Jan 31, 2024, 04:30 PM |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Jan 29, 2024 | Buy | $19.00 | 400,000 | 7,600,000 | 400,000 | Jan 31, 2024, 04:17 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | 01/29/2024 | 7,600,000 |
| Kasturi Vijay | Chief Medical Officer | 01/29/2024 | 24,985 |
| Roche Corleen M. | CFO & Secretary | 01/29/2024 | 38,000 |
| Song Hong Fang | Director | 01/29/2024 | 4,999,983 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | 01/29/2024 | 7,600,000 |
FUNDS WITH A POSITION IN CG ONCOLOGY INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 2,518,550 | 0.00257% | New | Other |
| HOLOCENE ADVISORS, LP | 766,625 | 0.12% | New | Growth At A Reasonable Price |
| GEODE CAPITAL MANAGEMENT, LLC | 504,216 | 0.00205% | New | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 455,000 | 0.04% | New | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 107,957 | 0.05% | New | Growth |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 47,540 | 0.04% | New | Other |
| BLACKSTONE INC. | 25,000 | 0.00443% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 14,200 | 0.00098% | New | Other |
BUYBACK ANNOUNCEMENT(S) FOR CG ONCOLOGY INC.
LOADING...